20/20’s Lung Cancer Detection Technology Launches in China

12:11 EDT 21 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
1st Machine Learning Approach Available to Hospitals to Aid in Evaluating Ambiguous Pulmonary Nodules 20/20 GeneSystems, Inc. ( (“20/20”) released this week in China what is believed to be the world’s ...

Other Sources for this Article

20/20 GeneSystems, Inc
Haley Faith, 240-453-6339 x108


More From BioPortfolio on "20/20’s Lung Cancer Detection Technology Launches in China"

Quick Search


Relevant Topics

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...